The second receptor is GIP, or glucose-dependent insulinotropic polypeptide
GG is certainly not a medical practitioner or in a position to judge anyones methods of weight loss
Oxyntomodulin has been shown to reduce bodyweight and food intake in rodents and humans [11, 12] and to increase energy expenditure in people with obesity [13], via activity at both receptors
slow, stepwise titration guided by clinical response and tolerance at each dose level Duration Determined by clinical goals, monitoring results, and physician assessment
This dual action is popular with fitness enthusiasts looking to gain muscle and lose fat
At Set Point Medical Weight Loss Clinic, we offer the latest, evidence-based medical treatments to help our patients achieve their weight loss goals safely and effectively